SCHEMBL763299

SCHEMBL763299

CC(C)(C)OC(=O)N[C@@H](CC(=O)N1CCC[C@@H](c2nc3ccccc3n2CCN2C(=O)c3ccccc3C2=O)C1)Cc1ccc2ccccc2c1

nearest known ligand 0.40

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 9/20 0.40
CYP2D6 P10635 7/20 0.40
KCNH2 Q12809 9/20 0.39
CHRM1 P11229 3/20 0.39
CTSB P07858 1/20 0.37
CTSS P25774 1/20 0.37
CTSK P43235 1/20 0.37
CYP3A4 P08684 1/20 0.37
RXRA P19793 1/20 0.36
RXRB P28702 1/20 0.36
RXRG P48443 1/20 0.36
ALDH1A1 P00352 1/20 0.35
PROKR1 Q8TCW9 1/20 0.35
USP2 O75604 1/20 0.35
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL742278 0.90 HRH1 (0.43) HRH1CYP2D6KCNH2CHRM1ALDH1A1
SCHEMBL762816 0.90 HRH1 (0.42) HRH1CYP2D6KCNH2CHRM1CTSB
SCHEMBL762687 0.88 HRH1 (0.41) HRH1CYP2D6KCNH2CHRM1CTSB
SCHEMBL762785 0.88 HRH1 (0.42) HRH1CYP2D6KCNH2CHRM1CTSB
SCHEMBL742306 0.83 HRH1 (0.41) HRH1CYP2D6KCNH2CHRM1PROKR1
SCHEMBL762577 0.82 CTSB (0.36) HRH1CYP2D6KCNH2CHRM1CTSB
SCHEMBL762559 0.82 KCNH2 (0.39) HRH1CYP2D6KCNH2CHRM1CTSB
SCHEMBL762648 0.82 HRH1 (0.36) HRH1CYP2D6KCNH2CHRM1CTSB
SCHEMBL10292140 0.82 PADI4 (0.37) HRH1CYP2D6KCNH2CHRM1CTSB
SCHEMBL763469 0.81 HRH1 (0.45) HRH1CYP2D6KCNH2CHRM1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138168-B1 Renin inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-03-20 US disclosed
US-8138168-B1 Renin inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-03-20 US disclosed